Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: Binding of 70-kilodalton heat shock proteins

Virology

Volumn 220, Issue 1, 1996, Pages 91-99

  Kitay, Mary Kate ^a   Rowe, David T ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; HEAT SHOCK PROTEIN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION;

HUMAN HERPESVIRUS 4;

EID: 0029894601     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0289     Document Type: Article

References (43)

1. Allan, G. J., Inman, G. J., Parker, B. D., Rowe, D. T., and Farrell, P. J. (1992). Cell growth effects of Epstein-Barr virus leader protein. J. Gen. Virol. 73, 1547-1551.
2. Allday, M. J., Crawford, D. H., and Griffin, B. (1989). Epstein-Barr Virus latent gene expression during the initiation of B cell immortalization. J. Gen. Virol. 70, 1755-1764.
3. Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H., and Farrell, P. J. (1995). Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14, 1382-1391.
4. Belyavskyi, M., Miller, J., and Wilson, V. (1994). The bovine papillomavirus E1 protein alters the host cell cycle and growth properties. Virology 204, 132-143.
5. Ben-Basset, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J. M., Coney, M. M., Bentwicch, Z, Ramot, B., Klein, E., and Klein, G. (1977). Establishment in continuous culture of a new type of lymphocyte from a "Burkitt-like" malignant lymphoma (line D.G.-75). Int. J. Cancer 19, 27-33.
6. Chen, P. L., Scully, P., Shew, J. Y., Wang, Y. J., and Lee, W. H. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 193-1198.
7. Cordier-Bussat, M., Billaud, M., Calender, A., and Lenoir, G. M. (1993). Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int. J. Cancer 53, 153-160.
8. Finke, J., Rowe, M., Kallin, B., Ernberg, I., Rosen, A., Dillner, J., and Klein, G. (1987). Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61, 3870-3878.
9. Finlay, C., Hinds, P., Frey, A. B., and Levine, A. J. (1988). Mutations which activate p53 transformation with ras produce an altered p53 protein that preferentially binds to a heat shock protein hsc70. Mol. Cell. Biol. 8, 531-539.
10. Flynn, G. C., Pohl, J., Flocco, M. T., and Rothman, J. E. (1991). Peptide binding specificity of the molecular chaperone BiP. Nature (London) 353, 726-730.
11. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 33-42.
12. Hammerschmidt, W., and Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
13. k. Science 265, 92-95.
14. Hightower, L. E. (1991). Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66, 191-197.
15. Hinds, P. W., Finlay, C. A., Frey, A. B., and Levine, A. J. (1987). Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p-53-plus-ras transformed cell lines. Mol. Cell. Biol. 7, 2863-2869.
16. Jang, W.-Q., Szekely, L., Wendel-Hansen, V., Ringertz, N., Klein, G., and Rosen, A. (1991). Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encloded nuclear antigen EBNA5. Exp. Cell Res. 197, 314-318.
17. Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., and Livingston, D. M. (1991). Identification of cellular proteins that can interact with the T/E1a-binding region of the retinoblastoma gene product. Cell 64, 521-432.
18. Keen, N., Elston, R., and Crawford, L. (1994). Interaction of the E6 protein of human papillomavirus with cellular proteins. Oncogene 9, 1493-1499.
19. Khanna, R., Burrows, S. R., and Moss, D. J. (1995). Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59, 387-405.
20. Klein, G. (1983). Chromosomal translocations and the genesis of B cell derived tumors in mice and men. Cell 32, 311-315.
21. Klein, G. (1994). Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77, 791-793.
22. Lehman, T. A., Bennett, W. P., Metclaf, R. A., Welsh, J. A., Ecker, J., Modali, R. V., Ullrich, S., Romano, J. W., Appella, E., Testa, J. R., Gerwin, B. I., and Harris, C. C. (1991). p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51, 4090-4096.
23. Leibowitz, D., and Kieff, E. (1990). Epstein-Barr virus and its replication. In "Fields Virology" (B. N. Fields, D. M. Knipe et al., Eds.), pp. 1889-1920. Raven Press, New York.
24. Lenoir, G. M., Vuillaume, M., and Bonnardel, C. (1985). Use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. In "Burkitt's Lymphoma: A Human Cancer Model" (G. M. Lenoir, G. O'Connor, and C. L. M. Olweny, Eds.), Scientific Publication No. 60, pp. 309-318. International Agency for Research on Cancer, Lyon, France.
25. Ling, P. D., Rawlins, D. R., and Hayward, S. D. (1993). The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA 90, 9237-9241.
26. Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A., and Kieff, E. (1991). The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65, 6826-6837.
27. Marshall, D., and Sample, C. (1995). Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69, 3624-3630.
28. Matsunami, N., Hamaguchi, Y., Yamamoto, Y., Kuze, K., Kangawa, K., Matsuo, H., Kawaichi, M., and Honjo, T. (1989). A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature 342, 934-937.
29. Mosialos, R., Birkenbach, M., Yalamanchili, R., Van Arsdale, T., Ware, C., and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-400.
30. r heat shock cognate protein. Cancer Res. 53, 1702-1705.
31. Palleros, D. P., Welch, W. J., and Fink, A. L. (1991). Interaction of hsp70 with unfolded proteins: Effects of temperature and nucleotides on the kinetics of binding. Proc. Natl. Acad. Sci. USA 88, 5719-5723.
32. Penn, I., Hammond, W., Brettschneider, L., and Starzl, T. E. (1969). Malignant lymphomas in transplantation patients. Transplant. Proc. 1, 106-112.
33. Rawlins, D. R., Milman, G., Hayward, S. D., and Hayward, G. S. (1985). Sequence specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 859-868.
34. Robertson, E., and Kieff, E. (1995). Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J. Virol. 691, 983-993.
35. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13, 3321-3328.
36. Smith, D. B., and Johnson, K. S. (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
37. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G., and Wiman, K. G. (1993). EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90, 5455-5459.
38. Thorley-Lawson, D. A., and Mann, K. P. (1985). Early events in EBV infection provide a model for B cell activation. J. Exp. Med. 162, 45-47.
39. Tsui, S., and Schubach, W. H. (1994). Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. J. Virol. 68, 4287-4294.
40. Waltzer, L., Logeat, F., Brou, C., Israel, A., Sergeant, A., and Manet, E. (1994). The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. 13, 5633-5638.
41. Whyte, P., Buckovich, K. J., Howitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., and Harlow, E. (1988). Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124-129.
42. Wilson, G., and Miller, G. (1979). Recovery of Epstein-Barr virus from non-producer neonatal human lymphoid cell transformants. Virology 95, 351-358.
43. Zimber-Strobl, U., Strobl, L. J., Meitinger, C., Hinrichs, R., Sakai, T., Furukawa, T., Honjo, T., and Bornkamm, G. W. (1994). The Epstein-Barr virus nuclear antigen 2 exerts its function through interaction with recombination signal binding protein RBP-J Kappa, the homologue of Drosophila suppressor of hairless. EMBO J. 13, 4973-4982.